• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconCOVID-19 vaccines

COVID-19 vaccines

Page 14 of 95
Moderna COVID-19 vaccine
HealthU.S. reaches $1.74 billion deal with Moderna for its Omicron-specific vaccine
By Zeke Miller and The Associated PressJuly 29, 2022
CommentaryHere’s what the pandemic really looks like in America’s medical deserts
By Daniel GreenleafJuly 28, 2022
fauci-covid-booster-omicron
HealthFauci calls BA.5 a ‘moving target’ that may subside by the time Omicron boosters are ready. Scientists are pushing for a universal COVID vaccine instead
By Grady McGregorJuly 28, 2022
CommentaryA global effort to stop the spread of COVID-19 in Africa is underway–and it starts with health care workers
By Adar PoonawallaJuly 27, 2022
TechFacebook considers relaxing COVID-19 misinformation policies
By Chris MorrisJuly 26, 2022
pharmacy-covid-china-pill-antiviral
HealthChina just approved its first domestic anti-COVID pill, Azvudine, and is ready to produce 6.8 billion pills a year at half the price of Pfizer’s Paxlovid
By Grady McGregorJuly 26, 2022
HealthPfizer’s anti-COVID pill — used by Biden — is expected to rake in $23.2 billion, but confusion and weak demand could cause supply glut
By Chloe TaylorJuly 25, 2022
Bill Gates
HealthThe Bill & Melinda Gates Foundation partly funded an Omicron variant study with a surprising conclusion about boosters
By Christine MuiJuly 21, 2022
novavax-covid-vaccine-laboratory
HealthThe U.S.’s woefully low COVID vaccination rate makes it Novavax’s most appealing market yet
By Grady McGregorJuly 20, 2022
Ampoules containing the Corona vaccine Nuvaxovid from the manufacturer Novavax
HealthCDC endorses Novavax COVID shot for adults, adding to the number of vaccine options
By Lauran Neergaard and The Associated PressJuly 19, 2022
CommentaryNew viral threats are moving fast. Here’s how we can move faster
By Gavin ClohertyJuly 18, 2022
Novavax-lab-vaccine-covid
HealthA ‘breadth of protection’: Novavax’s newly approved COVID vaccine arms the U.S. with a new weapon against Omicron BA.5 subvariant
By Grady McGregorJuly 14, 2022
CommentaryCOVID finally got me. Will it come for you?
By Carolyn BarberJuly 12, 2022
HealthAn Omicron vaccine is coming. Should you wait for it—or get your next booster now amid BA.5’s surge?
By Nicholas GordonJuly 12, 2022
HealthNew Omicron subvariants are causing COVID rates to increase. These are the states where it’s most contagious right now
By Andrew MarquardtJuly 11, 2022
1...
  • 12
  • 13
  • 14
  • 15
  • 16
...95
Most Popular
Economy
Trump may have shot himself in the foot at the Fed, as Powell could stay on while Miran resigns from White House postAn image of a popular article
By Eleanor PringleFebruary 4, 2026
Investing
Tech stocks go into free fall as it dawns on traders that AI has the ability to cut revenues across the boardAn image of a popular article
By Jim EdwardsFebruary 4, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.